AzTrials
AzTrials

Low Back PainNCT00479245

WHODAS-II for Patients With Nonspecific Low Back Pain

A study testing Set of questionnaires (respondent) in people with Low Back Pain, run by Kovacs Foundation at 1 site in Spain.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule), as well as to analyze its correlation with low back pain (Visual Analog Scale, VAS), disability (Spanish version of the Roland Morris Questionnaire, RMQ), fear… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Low Back Pain
What is being tested?
Set of questionnaires (respondent)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteSpain
Study dates
Apr 2007to Apr 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients seen for nonspecific low back pain, with or without referred pain
  • Able to read and write
  • Have signed the informed consent form

Who cannot join

  • Central nervous system pathology (with or without treatment)
  • Diagnosis of rheumatic inflammatory disease or fibromyalgia
  • Red flags for underlying systemic disease
  • Criteria for diagnosis of symptomatic herniated disc or symptomatic spinal stenosis

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitario Marqués de Valdecilla

    Santander, Cantabria, 39008

Other trials in Spain

About this study

The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule), as well as to analyze its correlation with low back pain (Visual Analog Scale, VAS), disability (Spanish version of the Roland Morris Questionnaire, RMQ), fear avoidance beliefs and attitudes (Spanish version of the FAB Questionnaire, FABQ) and quality of life (SF-12). Measurements will be taken at baseline and 6 days later (day 7).

Conditions
Low Back Pain
Being tested
Set of questionnaires (respondent)
Keywords
nonspecific low back pain, disability, fear avoidance beliefs, quality of life
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Set of questionnaires (respondent)Other

    To determine the measurement characteristics of WHODAS II (World Health Organization Disability Assessment Schedule)

Study groups in NCT00479245
Study groupRoleWhat they receive
1OtherMeasurement characteristics of WHODAS II (World Health Organization Disability Assessment Schedule)
Receives: Other: Set of questionnaires (respondent)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement characteristics of WHODAS-II

    Measured: At baseline and at 7 days

Secondary outcomes (1)
  1. Correlation between WHODAS-II and VAS, RMQ, FABQ and SF-12 in nonspecific low back pain

    Measured: At baseline and at 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2007 (estimated)
  2. Study startApr 2007
  3. Primary completionApr 2011
  4. Study completionApr 2011

Why it stopped: Recruitment rate, lower than expected. Organizational changes made it impossible for recruiting centers to continue

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00479245
Sponsor's protocol ID
FK-R-17
Status last verified
Jun 2011
First submitted
25 May 2007
Last updated
28 Jun 2011
Results posted
No
Data monitoring committee
Yes

Publications

  • Bombardier C. Outcome assessments in the evaluation of treatment of spinal disorders. Introduction. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3097-9. doi: 10.1097/00007632-200012150-00002. No abstract available.

    PubMed 11124723
  • Chwastiak LA, Von Korff M. Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO DAS II) in a primary care setting. J Clin Epidemiol. 2003 Jun;56(6):507-14. doi: 10.1016/s0895-4356(03)00051-9.

    PubMed 12873644
  • van Tubergen A, Landewe R, Heuft-Dorenbosch L, Spoorenberg A, van der Heijde D, van der Tempel H, van der Linden S. Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis. 2003 Feb;62(2):140-5. doi: 10.1136/ard.62.2.140.

    PubMed 12525383

Questions about this trial

What is this clinical trial studying?

A study testing Set of questionnaires (respondent) in people with Low Back Pain, run by Kovacs Foundation at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 28 Jun 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Recruitment rate, lower than expected. Organizational changes made it impossible for recruiting centers to continue). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement characteristics of WHODAS-II (time frame: At baseline and at 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00479245, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jun 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in